Newly licensed drugs
- PMID: 8963199
- PMCID: PMC2352471
- DOI: 10.1136/bmj.313.7066.1157
Newly licensed drugs
Comment in
-
Interferon beta in multiple sclerosis. Current policy is sensible.BMJ. 1997 Feb 22;314(7080):600-1. BMJ. 1997. PMID: 9055728 Free PMC article. No abstract available.
-
Interferon beta in multiple sclerosis. Interferon beta reduces overall relapse rate by one third.BMJ. 1997 Feb 22;314(7080):601. BMJ. 1997. PMID: 9055729 Free PMC article. No abstract available.
-
Interferon beta in multiple sclerosis. Avoidance of the need for social care should also be taken into account.BMJ. 1997 Feb 22;314(7080):601. BMJ. 1997. PMID: 9055730 Free PMC article. No abstract available.
-
Interferon beta in multiple sclerosis. Relapses deserve treatment.BMJ. 1997 Feb 22;314(7080):602. BMJ. 1997. PMID: 9055732 Free PMC article. No abstract available.
-
Interferon beta in multiple sclerosis. Some form of compromise must be accepted.BMJ. 1997 Feb 22;314(7080):602. BMJ. 1997. PMID: 9055733 Free PMC article. No abstract available.
-
New antiepileptic drugs. Register of women who take the drugs during pregnancy has been set up.BMJ. 1997 Feb 22;314(7080):603. BMJ. 1997. PMID: 9055736 Free PMC article. No abstract available.
-
Newly licensed drugs. A probationary period is a good idea.BMJ. 1997 Feb 22;314(7080):604. doi: 10.1136/bmj.314.7080.604a. BMJ. 1997. PMID: 9055739 Free PMC article. No abstract available.
-
Newly licensed drugs. Randomised controlled trials are needed in primary care before new drugs are licensed.BMJ. 1997 Feb 22;314(7080):604-5. BMJ. 1997. PMID: 9055740 Free PMC article. Clinical Trial. No abstract available.
-
Newly licensed drugs. "Proportionate benefits" should be made clear.BMJ. 1997 Feb 22;314(7080):605. BMJ. 1997. PMID: 9055741 Free PMC article. No abstract available.
-
Newly licensed drugs. Doctors should be encouraged to report adverse reactions.BMJ. 1997 Feb 22;314(7080):605. BMJ. 1997. PMID: 9055742 Free PMC article. No abstract available.
Comment on
-
Drug trials in epilepsy.BMJ. 1996 Nov 9;313(7066):1158. doi: 10.1136/bmj.313.7066.1158. BMJ. 1996. PMID: 8916729 Free PMC article. No abstract available.
-
Interferon beta in multiple sclerosis.BMJ. 1996 Nov 9;313(7066):1159. doi: 10.1136/bmj.313.7066.1159. BMJ. 1996. PMID: 8916730 Free PMC article. No abstract available.
-
New antiepileptic drugs: a systematic review of their efficacy and tolerability.BMJ. 1996 Nov 9;313(7066):1169-74. doi: 10.1136/bmj.313.7066.1169. BMJ. 1996. PMID: 8916746 Free PMC article.
-
Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.BMJ. 1996 Nov 9;313(7066):1184-5. doi: 10.1136/bmj.313.7066.1184. BMJ. 1996. PMID: 8916751 Free PMC article. No abstract available.
-
A purchaser experience of managing new expensive drugs: interferon beta.BMJ. 1996 Nov 9;313(7066):1195-6. doi: 10.1136/bmj.313.7066.1195. BMJ. 1996. PMID: 8916757 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources